A prospective, multicenter cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has validated an ...

An ECOG-ACRIN imaging study solves a long-standing gap in metastatic breast cancer research and care: accurately measuring ...

A prospective, multicenter cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has validated an ...

A prospective, multicenter cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has validated an improved method for predicting ...

With a nudge from comedian Tig Notaro, the filmmaker turned his camera on poet-activist Andrea Gibson and the last months of ...

Australians living with multiple sclerosis and rare cancers will now have access to life-changing medicines thanks to new listings on the ...

Alessandro Antonicelli died earlier this month after battling his health issues for almost two years along with being hospitalized.

A single mother had to quit working to care for her daughter when the 3-year-old was diagnosed with metastatic cancer. They need your help to pay the rent.

Blueprint Medicines, a Sanofi company, today announced updated data reinforcing the clinical efficacy and safety of long-term AYVAKIT® (avapritinib) use across the spectrum of systemic mastocytosis ...

There’s something uniquely frightening about diseases that affect the brain. Unlike a broken bone or an inflamed joint, brain conditions often come with fewer treatment options — and far higher risks.

The heart-wrenching journey of Nicole Casellas, a three-year-old Cuban girl battling a severe pediatric cancer, has touched the hearts of the Miami ...

ELZONRIS was approved by the FDA in December 2018 for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adult and pediatric patients two years and older, in both treatment-naïve ...